Journals / Osmangazi Tıp Dergisi / 2020 / Cilt: 42 - Sayı: 1

Therapeutic Plasma Exchange Indications, Complications and Responses : A Single Center, Retrospective Analysis.

Terapo tik Plazma Deg işimi Endikasyonları, Komplikasyonları ve Yanıtları; Tek Merkez, Retropsektif Analiz Sonuçları

Pages
14–26
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result; TPE is a useful, easy and effective life saving treatment with few side effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Therapeutic plasma exchange (TPE) is a process that allows high molecular weight substances to be removed fromplasma.
📊
Key Findings & Data:Current guidelines onthis process have been published in recent years due to increased awareness and accessibility.
💡
Conclusion & Impact:As a result; TPE is a useful, easy and effective life saving treatment with few side effects.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Therapeutic plasma exchange (TPE) is a process that allows high molecular weight substances to be removed fromplasma. Therapeutic plasma exchange is widely used in many diseases in the practice of internal medicine. Current guidelines onthis process have been published in recent years due to increased awareness and accessibility. The most common and mostcomprehensive of these is the American Apheresis Society (ASFA) guideline. In this study, we retrospectively determined thedemographic data, underlying diseases, biochemical parameters, volume and type of replacement fluid, complications developedduring and after the procedure, additional treatments, need for dialysis, and the number of sessions for patients who underwenttherapeutic plasma exchange for any reason in the internal medicine clinic aimed to reveal aspects that can be improved in clinicalpractice. In the study, 117 patients between 2007 and 2016 were evaluated retrospectively. Of all cases, 63 (53.8%) were female. Atthe time of diagnosis, the mean age of the patients was 52.15 ± 16.8 (20-88) years. The most common indications for TPE werethrombotic thrombocytopenic purpura (TTP) and ANCA-associated vasculitis. Fresh frozen plasma and albumin were the mostcommonly used replacement fluids. Catheter related complication rate was 5.1%. The rate of complication related to TPE duringTPE was 19.6%. No fatal reactions to TPE treatment were observed. There was a significant relationship between alkalinephosphatase (ALP) and mortality when the relationship between the laboratory data and the mortality rate of the patients with TTPwas considered (p = 0.002). There was a significant correlation between chlorine and hematocrit and mortality in ANCA-associatedvasculitis patients (p = 0.029 and p= 0.037, respectively). For the purpose of estimating mortality, further work is needed to confirmthe validity of these laboratory data. As a result; TPE is a useful, easy and effective life saving treatment with few side effects.

Özet

: Terapötik plazma değişimi (TPD) plazmadan yüksek molekül ağırlıklı maddelerin uzaklaştırılmasını sağlayan bir işlemdir. Terapötik plazma değişimi işlemi iç hastalıkları pratiğinde birçok hastalıkta yaygın olarak kullanılmaktadır. Bu işlem ile ilgili son yıllarda farkındalığın ve ulaşılabilirliğin artmasına bağlı olarak güncel kılavuzlar yayımlanmaktadır. Bunlardan en genel geçer ve kapsamlı olanı Amerikan Aferez Cemiyeti (ASFA)’nin yayımladığı kılavuzdur. Bu çalışmada, iç hastalıkları kliniğinde herhangi bir nedenle terapötik plazma değişimi yapılan hastaların demografik verilerini, altta yatan hastalıklarını, biyokimyasal parametrelerini, replasman sıvısının volümü ve tipini, işlem sırasında ve sonrasında gelişen komplikasyonları, ek tedavileri, diyaliz ihtiyacı olup olmadığını, seans sayılarını retrospektif olarak belirleyerek klinik pratikte geliştirilebilecek yönleri ortaya koyabilmek amaçlandı. Çalışmada 2007 ve 2016 yılları arasındaki, 117 hasta retrospektif olarak değerlendirildi. Tüm olguların 63 (%53,8)’ü kadın, 54 (%46,2)’ü erkekti. Tanı anında hastaların yaş ortalaması 52,15 ± 16,8 (20-88) yıl idi. En sık TPD endikasyonu TTP ve ANCA ilişkili vaskülit idi. Taze donmuş plazma ve albümin en sık kullanılan replasman sıvılarıydı. Katater ilişkili komplikasyon oranı %5,1 idi. TPD süresince TPD ilişkili komplikasyon oranı %19,6 idi. TPD işlemi ile ilgili herhangi bir fatal reaksiyona rastlanılmadı. TTP tanılı hastaların başvuru anındaki laboratuvar verileri ile mortalite arasındaki ilişkiye bakıldığında ALP ve mortalite arasında anlamlı bir ilişki bulundu (p= 0.002). ANCA ilişkili vaskülit hastalarında ise klor ve hematokrit ile mortalite arasında anlamlı bir ilişki bulundu (sırasıyla p = 0.029, p= 0.037). Mortaliteyi tahmin etmede kullanım amacıyla, bu laboratuvar verilerinin teyidi için ileri çalışmalara ihtiyaç vardır. Sonuç olarak; TPD, çok az yan etki ile faydalı, kolay ve etkili bir hayat kurtaran tedavi yöntemidir.

🔖

Cite This Article

Cansu, D. Ü., Ozkan, B., Teke, H. U., Sahin, G. (2022). Therapeutic Plasma Exchange Indications, Complications and Responses : A Single Center, Retrospective Analysis.. Osmangazi Tıp Dergisi, Cilt: 42 - Sayı: 1, 14–26. https://ajindex.com/articles/586096

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sengul Samanci N, Ayer M, Gursu M, et al. Patients treated with therapeutic plasma exchange: a single center experience. Transfus Apher Sci. 2014;51:83-9.
  2. Eren G, Çukurova Z, Kucur E, et al., Our Experience on Therapeutic Plasmapheresis Performed for A Variety of Clinical Indications in Our Intensive Care Unit Turkiye Klinikleri J Med Sci 2010;30:1683-9
  3. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991; 8;325:393-7.
  4. Allford SL, Hunt BJ, Rose P, Machin SJ;Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology: Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol., 2003. 120: p. 556-73.
  5. Scully M, Hunt BJ, Benjamin S, et al., Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158: 323-35.
  6. Szczepiorkowski ZM, Winters JL, Bandarenko N et al., Guidelines on the use of therapeutic apheresis in clinical practice evidence‐based approach from the apheresis applications committee of the American Society for Apheresis. J Clin Apher. 2010;25:83-177.
  7. Schwartz J, Winters JL, Padmanabhan A,et al., Guidelines on the use of therapeutic apheresis in clinical practice-evidence‐based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28:145-284.
  8. Agishi, T., Spectrum of blood purification. Prog Med, 1985;134: 861-64.
  9. Huestis, DW, Bove JR, Busch S. Practical blood transfusion. Little Brown and Company. 1981 Barnes A. Hemapheresis perspectives. Terapeutic Apheresis. Arlington, Virginia: American Association of Blood Banks, 1983: p. 1-13.
  10. Shaz BH, Schwartz J, Winters JL. How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedures. Transfusion, 2014;54: 17-25.
  11. Toprak SK, İlhan O. Current Legislation in Therapeutic Apheresis and National Therapeutic Apheresis Guideline: Where Do We Stand in 2015? Turkiye Klinikleri J Hematol-Special Topics 2015;8:104-14
  12. Korkmaz S, Keklik M, Sivgin S et al., Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study. Transfus Apher Sci. 2013;48:353-8.
  13. Kim JW, Kim I, Oh KH et al., Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpu